|

[18F]MK6240 Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: [18F-MK6240]

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

  • Yale University1
  • Washington University School of Medicine1
  • Patrick Lao1

Indications

  • Alzheimer's Disease3
  • Alzheimer Disease2
  • Spinal Radiculopathy1
  • MS (Multiple Sclerosis)1
  • Demyelinating Disorders1

New Haven, Connecticut1 trial

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

Yale University PET Center

Phase 1

St Louis, Missouri1 trial

R21 Roche: 3-Way Tau Tracers in AD

Washington University School of Medicine

Phase 1

New York, New York1 trial

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

Columbia University Irving Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.